ArticleFrontiers in reproductive health2026
Women's autonomy and discrimination relevant to cervical cancer screening.
Article in Frontiers in reproductive health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Introduction: Cervical cancer remains the fourth most common cancer affecting women worldwide, with large geographical variations in incidence and mortality rates. The objective of this study is to determine whether women's autonomy is predictive of the use of cervical cancer screening services in Senegal. Method: This was a descriptive and analytical cross-sectional study of a sample of 312 women. Data were analyzed using R 4.2 software. Logistic regression was used to analyze associations between indicators of women's autonomy and cervical cancer screening practices. Results: Compared with women whose partners made the decision regarding cervical cancer screening, women who reported making the decision themselves (AOR: 10.07; 95% CI: 2.72, 37.33) or jointly with their partner (AOR: 5.34; 95% CI: 1.35, 21.21) were more likely to have undergone screening. Women who were aware of the existence of a cervical cancer screening test were also more likely to have been screened than those who were not aware of it (AOR: 7.67; 95% CI: 1.41, 41.61). In contrast, women residing in Dakar were more likely to have undergone cervical cancer screening than those residing in the Kédougou region (AOR: 0.40; 95% CI: 0.17, 0.96). Conclusion: This study shows that increased autonomy among women predicts greater use of cervical cancer screening services by women. Therefore, policy interventions should focus on empowering women to make autonomous decisions about their health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.